Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results